A23V 2250/184
Emulsifier
Official title: Emulsifier (emulsifier as function A23V2200/222)
A23V2250/184 (Emulsifier) appears on 28 US grants and 62 published applications in this corpus.
Search patents in A23V- Granted patents
- 28
- Published applications
- 62
- Assignees
- 36
- Inventors
- 141
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 2 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 3 |
| 2016 | 0 | 2 |
| 2017 | 1 | 7 |
| 2018 | 1 | 16 |
| 2019 | 3 | 12 |
| 2020 | 7 | 6 |
| 2021 | 3 | 1 |
| 2022 | 4 | 7 |
| 2023 | 0 | 4 |
| 2024 | 3 | 1 |
| 2025 | 3 | 1 |
| 2026 | 2 | 0 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Nutritional compositions and infant formula for promoting de novo myealination21 Jul 2026US 12,685,331 B2Societe des Produits Nestle S. A.
- Shelf-stable nitrogenous organic acid compositions10 Mar 2026US 12,568,993 B2Glanbia Dairy Nutrition Limited
- Nutritional composition and infant formula for promoting de novo myelination2 Dec 2025US 12,484,608 B2Societe des Produits Nestle S. A.
- Edible composition for alleviating visual fatigue14 Oct 2025US 12,440,532 B2Shanghai Lytone Biochemicals, LTD.
- Metastable, translucent flavor nanoemulsion and methods of preparing the same25 Mar 2025US 12,256,753 B2International Flavors & Fragrances Inc.
- Compositions and their use11 Sep 2025US 2025/0280863 A1Societe des Produits Nestle S. A.
- Nutritional composition and infant formula for promoting de novo myelination24 Oct 2024US 2024/0349771 A1Societe des Produits Nestle S. A.
- Method for reducing amount of sugar used in chocolate27 Jul 2023US 2023/0232857 A1Fuji Oil Holdings Inc.
- Edible composition for alleviating visual fatigue16 Feb 2023US 2023/0048358 A1Shanghai Lytone Biochemicals, LTD.
- Nutritional compositions and infant formula for promoting de novo myealination19 Jan 2023US 2023/0015563 A1Societe des Produits Nestle S. A.
Most cited
By later US patents
- Dietary supplement compositions including cannabidiol formulations having enhanced bioavailability with sustained time release and enhanced organoleptics, and methods of making same3US 11,252,985 B1Cannasphere Biotech, LLC. · 2022
- Lipid supplements for maintaining health and treatment of acute and chronic disorders3US 8,877,239 B2Nutritional Therapeutics, Inc. · 2014
- Nutritional formulations using human milk oligosaccharides for modulating inflammation2US 10,624,916 B2Abbott Laboratories · 2020
- Edible and thermoreversible oleogel and method for preparation thereof2US 10,874,115 B2Sigma Alimentos, S.A. De C.V. · 2020
- Gel capsule containing sterol and solubilising agent1US 10,188,133 B2BASF SE · 2019